GSK Stock - Glaxosmithkline ADR

GSK Stock Chart

GSK Profile

GSK plc, along with its subsidiaries, is actively involved in the development, manufacturing, and global marketing of pharmaceuticals, vaccines, over-the-counter medicines, and health-related consumer products. Headquartered in Brentford, United Kingdom, the company operates through four distinct segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Its pharmaceutical portfolio spans various therapeutic areas including respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular, urogenital, metabolic, anti-bacterial, and dermatology.

In addition to pharmaceuticals, GSK offers a wide range of consumer healthcare products across welness, oral health, nutrition, and skin health categories. These products are available in diverse formats such as nasal sprays, tablets, syrups, lozenges, gum, trans-dermal patches, caplets, infant syrup drops, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams, non-medicated patches, lip balm, gummies, and soft chews.

Founded in 1715 and formerlly known as GlaxoSmithKline plc before changing its name to GSK plc in May 2022, the company maintains strategic collaborations with leading biotech firms and pharmaceutical companies worldwide. These partnerships, including those with Novartis, Sanofi, and Vir Biotechnology, underscore GSK's commitment to advancing medical research and innovation. GSK continues to leverage its extensive expertise and global reach to enhance healthcare outcomes and meet the evolving needs of patients and consumers globally.

GSK Revenue Chart

GSK Earnings

Analyst Ratings